<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: medical therapy</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Hope for patients with type 2 diabetes</title>
   	 <description>The outlook for individuals with type 2 diabetes and coronary artery disease is not as grim as originally believed, according to new Saint Louis University research published in Circulation, the Journal of the American Heart Association.</description>
     <link>http://www.physorg.com/news179059806.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 03 Dec 2009 11:00:03 EST</pubDate>
	 <guid isPermaLink="false">news179059806</guid>
</item>
<item>
     <title>Smoking remains potent risk factor for death from heart disease, cancer</title>
   	 <description>(PhysOrg.com) -- Smoking persists as a major risk factor for death from heart disease and cancer in adults who already have heart disease and receive good medical therapy, according to research reported in Circulation: Journal of the American Heart Association.</description>
     <link>http://www.physorg.com/news178219773.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 23 Nov 2009 17:40:05 EST</pubDate>
	 <guid isPermaLink="false">news178219773</guid>
</item>
<item>
     <title>New treatments offer better survival and fresh challenges in colorectal cancer</title>
   	 <description>Colorectal cancer (CRC) is the second leading cause of cancer-related death in the Western world. Fortunately physicians today have an abundance of drug therapies available to improve survival length for more advanced cancer patients. Now the discovery of genetic biomarkers relevant to CRC means that targeted personalised medication is increasingly common.</description>
     <link>http://www.physorg.com/news170073793.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 21 Aug 2009 12:10:01 EST</pubDate>
	 <guid isPermaLink="false">news170073793</guid>
</item>
<item>
     <title>Bone marrow stem cell co-transplantation prevents embryonic stem cell transplant-associated tumors</title>
   	 <description>Transplanted embryonic stem cells are recognized as a potential treatment for patients suffering from the effects of spinal cord injury (SCI). However, in studies using embryonic stem cells transplanted into SCI laboratory animals, a serious drawback has been the development of tumors following transplantation.</description>
     <link>http://www.physorg.com/news161267482.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 11 May 2009 13:31:51 EST</pubDate>
	 <guid isPermaLink="false">news161267482</guid>
</item>
<item>
     <title>Stenting not necessary in late treatment of heart attacks</title>
   	 <description>Two years ago, a major study found that many patients who receive delayed treatment for a heart attack do just as well with drugs alone as they do with drugs plus stents to prop open their blocked arteries. Now, further analysis shows that the drug option is cheaper and that there is no meaningful long-term difference in quality of life between the two options.</description>
     <link>http://www.physorg.com/news154201447.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 18 Feb 2009 17:45:05 EST</pubDate>
	 <guid isPermaLink="false">news154201447</guid>
</item>
<item>
     <title>Deep brain stimulation treatment for advanced Parkinson's disease patients provides benefits</title>
   	 <description>Patients with advanced Parkinson disease (PD) who received deep brain stimulation treatment had more improvement in movement skills and quality of life after six months than patients who received other medical therapy, but also had a higher risk of a serious adverse events, according to a study in the January 7 issue of JAMA.</description>
     <link>http://www.physorg.com/news150483770.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 06 Jan 2009 17:02:50 EST</pubDate>
	 <guid isPermaLink="false">news150483770</guid>
</item>
<item>
     <title>Surgery unnecessary for 95 percent of those with asymptomatic carotid stenosis</title>
   	 <description>Research led by Dr. David Spence of Robarts Research Institute at The University of Western Ontario shows that with more intensive medical therapy, the risk of stroke has become so low that at least 95 per cent of patients with asymptomatic carotid stenosis (ACS) would be better off with medical therapy than with surgery or stenting.  ACS is a narrowing in the carotid artery, which supplies blood to the brain, which has not yet resulted in a stroke or transient ischemic attack (TIA). In the United States, one-half to two-thirds of the patients being subjected to surgery for revascularization are asymptomatic.</description>
     <link>http://www.physorg.com/news141539312.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 25 Sep 2008 05:28:32 EST</pubDate>
	 <guid isPermaLink="false">news141539312</guid>
</item>


</channel>
</rss>

